Pharmaceutical - Diabetes, USA

Filter

Current filters:

DiabetesUSA

Popular Filters

1 to 25 of 35 results

Takeda and Lilly’s fine is reduced in Actos case

Takeda and Lilly’s fine is reduced in Actos case

28-10-2014

A US district court has reduced the damages to be paid by Japan’s largest drugmaker Takeda Pharmaceutical…

ActosDiabetesEli LillyLegalPharmaceuticalTakeda PharmaceuticalUSA

Novo Nordisk subpoenaed by US Attorney

Novo Nordisk subpoenaed by US Attorney

25-10-2014

Danish diabetes care giant Novo Nordis on Friday revealed it had been served with a subpoena by the office…

DenmarkDiabetesLegalNovo NordiskPharmaceuticalProductionUSA

Age is a factor when looking at diabetes management, Sanofi survey finds

Age is a factor when looking at diabetes management, Sanofi survey finds

15-10-2014

The US subsidiary of French pharma major Sanofi has announced the findings of a new survey that reveals…

DiabetesPharmaceuticalResearchSanofiUSA

Attack type 2 diabetes from a new direction, says new research

Attack type 2 diabetes from a new direction, says new research

06-10-2014

Type 2 diabetes affects an estimated 28 million Americans, according to the American Diabetes Association,…

DiabetesEndocrine systemPharmaceuticalResearchUSAVictor Shengkan Jin

Takeda responds to verdict in US Actos case; invests in vaccines firm

Takeda responds to verdict in US Actos case; invests in vaccines firm

06-10-2014

The US subsidiary of Japan’s largest drugmaker Takeda Pharmaceuticals says that in the case of Frances…

ActosAlfresa CorpDiabetesJapanLegalMergers & AcquisitionsPharmaceuticalTakeda PharmaceuticalUSAVaccine Safe CoVaccines

Intarcia’s Phase III diabetes data shows sustained blood sugar control

Intarcia’s Phase III diabetes data shows sustained blood sugar control

02-10-2014

USA-based Intarcia Therapeutics has announced successful top-line results from two of its four Phase…

DiabetesExenatide InjectionIntarcia TherapeuticsPharmaceuticalResearchUSA

FDA approves Lilly’s Trulicity to treat type 2 diabetes

FDA approves Lilly’s Trulicity to treat type 2 diabetes

19-09-2014

The US Food and Drug Administration yesterday approved pharma major Eli Lilly’s Trulicity (dulaglutide),…

BydureonDiabetesdulaglutideEli LillyPharmaceuticalRegulationTanzeumTrulicityUSAVictoza

The FDA publishes Novo Nordisk briefing documents ahead of Saxenda Advisory Committee meeting

The FDA publishes Novo Nordisk briefing documents ahead of Saxenda Advisory Committee meeting

09-09-2014

The US Food and Drug Administration has published briefing documents on Danish insulin giant Novo Nordisk’s…

Anti-diabetic drugsDiabetesliraglutideNovo NordiskPharmaceuticalRegulationTreatment of obesityUSA

Takeda and Lilly fail to overturn $9 billion award for hiding cancer risk of Actos

Takeda and Lilly fail to overturn $9 billion award for hiding cancer risk of Actos

31-08-2014

Japan’s largest drugmaker Takeda Pharmaceutical and US pharma major Eli Lilly have failed in their…

ActosDiabetesEli LillyFinancialLegalPharmaceuticalTakeda PharmaceuticalUSA

FDA approves Janssen’s Invokamet for diabetes

09-08-2014

The US Food and Drug Administration has approved US health care giant Johnson & Johnson subsidiary Janssen…

DiabetesInvokametInvokanaJanssenJohnson & JohnsonPharmaceuticalRegulationUSA

US FDA approves Jardiance for adults with type 2 diabetes

US FDA approves Jardiance for adults with type 2 diabetes

02-08-2014

The US Food and Drug Administration on Friday approved Jardiance (empagliflozin) tablets as an adjunct…

Boehringer IngelheimDiabetesEli LillyEuropeGermanyJardiancePharmaceuticalRegulationUSA

Sanofi's NDA for basal insulin Toujeo accepted by FDA

Sanofi's NDA for basal insulin Toujeo accepted by FDA

08-07-2014

The US Food and Drug Administration has accepted for review French pharma major Sanofi’s New Drug Application…

DiabetesPharmaceuticalRegulationSanofiToujeoUSA

Glowing prospects for Novo Nordisk's insulin degludec/liraglutide for type 2 diabetes

Glowing prospects for Novo Nordisk's insulin degludec/liraglutide for type 2 diabetes

07-07-2014

Danish diabetes care giant Novo Nordisk's fixed-dose combination therapy insulin degludec/liraglutide…

DiabetesEuropeIDegLiraMarkets & MarketingNovo NordiskPharmaceuticalUSAXultophy

FDA approves MannKind’s Afrezza to treat diabetes

FDA approves MannKind’s Afrezza to treat diabetes

30-06-2014

In a much awaited decision, the US Food and Drug Administration on Friday approved MannKind Corp’s…

AfrezzaDiabetesMannKindPharmaceuticalRegulationUSA

FDA review of CV risks for diabetics taking olmesartan not conclusive

FDA review of CV risks for diabetics taking olmesartan not conclusive

25-06-2014

The US Food and Drug Administration has completed its safety review and has found no clear evidence of…

BenicarCardio-vascularDaiichi SankyoDiabetesolmesartanPharmaceuticalRegulationUSA

Novo Nordisk launch new insulin device Levemir FlexTouch in USA

Novo Nordisk launch new insulin device Levemir FlexTouch in USA

19-06-2014

Danish diabetes care giant Novo Nordisk has launched its newest prefilled insulin delivery device Levemir…

DiabetesLevemirMarkets & MarketingNovo NordiskPharmaceuticalUSA

Boehringer and Lilly re-file empagliflozin NDA with FDA

Boehringer and Lilly re-file empagliflozin NDA with FDA

19-06-2014

The US subsidiary of German family-owned drugmaker Boehringer Ingelheim and pharma major Eli Lilly have…

Boehringer IngelheimDiabetesEli LillyempagliflozinPharmaceuticalRegulationUSA

Large increase seen in insulin use, out-of-pocket costs for type 2 diabetes

11-06-2014

Largely attributable to the widespread adoption of insulin analogs, use of insulin among patients with…

DiabetesHealthcarePharmaceuticalPricingUSA

Jury finds in favor of Takeda in diabetes drug Actos case

23-05-2014

The US subsidiary of Japan’s largest drugmaker, Takeda Pharmaceuticals, yesterday announced that in…

ActosDiabetesLegalPharmaceuticalTakeda PharmaceuticalsUSA

FDA finally OKs GlaxoSmithKline’s Tanzeum to treat type 2 diabetes

FDA finally OKs GlaxoSmithKline’s Tanzeum to treat type 2 diabetes

16-04-2014

UK pharma giant GlaxoSmithKline yesterday received the much anticipated approval from the US Food and…

albiglutideDiabetesGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationTanzeumUSA

NDA filing for empagliflozin and linagliptin combo accepted by FDA

NDA filing for empagliflozin and linagliptin combo accepted by FDA

14-04-2014

The US Food and Drug Administration has accepted the filing of the New Drug Application for the investigational…

Boehringer IngelheimDiabetesEli LillyempagliflozinJardiancelinagliptinNorth AmericaPharmaceuticalRegulationTradjentaUSA

1 to 25 of 35 results

Back to top